Published in Obesity and Diabetes Week, June 16th, 2008
"Patients received sequential, primed stepwise intravenous infusions of glulisine, lispro or RHI...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.